Sarah Brophy
Sarah is the Global Scientific Director for Element's Extractable and Leachables (E&L) services across our global Life Sciences business. Responsible for ensuring the successful scientific strategy, operations, and implementation of the E&L analytical services.
Prior to her current role, Sarah was the Director of Analytical Services at Element's facility in Bend, Oregon. She has over 17 years of experience focusing on E&L and analytical chemistry.
Experience
Sarah is responsible for ensuring the successful scientific strategy, operations, and implementation of the E&L analytical services. She manages Element’s E&L technical programs, as well as global projects focused on the strategic and technical objectives of Element’s Life Sciences Business Unit.
Prior to her current role, Sarah was the Director of Analytical Services at Element's facility in Bend, Oregon. She has over 17 years of experience focusing on E&L and analytical chemistry.
Career Highlights
Sarah has served in a variety of roles over her career, helping manufacturers of pharmaceutical, biologic, medical device and combination products keep up with ever increasing demands for product testing.
Her prior roles include:
- Analytical Chemist (Apr 2006 - Mar 2013)
- Senior Scientist/Study Manager (Mar 2013 – Jul 2019)
- Director of Analytical Services (Jul 2019 – Dec 2022)
- Global Scientific Director, Extractable and Leachables (Jan 2023 – present)
Qualifications and Credentials
- Bachelor’s in Chemistry from Oregon State University
- 17+ years of experience in E&L and analytical chemistry
Extractables & Leachables Studies
Element has one of the largest and most experienced extractables and leachables (E&L) practices in the world.
Backed by regulatory expertise, extensive experience, and a vast extractables database, our comprehensive E&L solutions ensure the safety of materials used across the healthcare sector.
We deliver tailored studies for pharmaceutical, biologic, medical device, reduced risk, combination products and more, in accordance with regulatory expectations.
